VITAMIN SPECIALTIES' ACQUISITION OF JASON PHARMACEUTICALS
• By The Tan Sheet
VITAMIN SPECIALTIES' ACQUISITION OF JASON PHARMACEUTICALS puts the Wyncote, Pa.-based dietary supplement retailer and manufacturer on target to generate 1995 sales in the $18-20 mil. range, Vitamin Specialties said. Vitamin Specialties announced Oct. 4 that it has entered an agreement in principle to acquire the privately held Jason Pharmaceuticals, a Baltimore-based developer, manufacturer and distributor of weight management and medical nutritional products marketed under the Medifast name.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A survey asks FDA staff to disclose whether DEI policies caused discrimination or resulted in disciplinary action against career employees over the past five years, but uses a web form that the general public also can access.
Clarity on what transferable exclusivity vouchers may look like for new antimicrobial drugs could be nearing. Denmark’s new presidency of the Council of the EU has prioritized concluding its negotiations with European Parliament over the legislative overhaul of the EU’s pharmaceutical legislation.
After pursuing Alchem International for breaches of EU antitrust rules – relating to a cartel over the SNBB pharmaceutical ingredient used in Buscopan and its generics – the European Commission has now hit the firm with a €489,000 fine.